Poland · Delayed Price · Currency is PLN Stem Cells Spin Statistics
Total Valuation
Stem Cells Spin has a market cap or net worth of PLN 16.12 million. The enterprise value is 16.26 million.
| Market Cap | 16.12M |
| Enterprise Value | 16.26M |
Important Dates
The last earnings date was Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Stem Cells Spin has 41.34 million shares outstanding.
| Current Share Class | 39.64M |
| Shares Outstanding | 41.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.39% |
| Owned by Institutions (%) | n/a |
| Float | 7.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 247.34 |
| PB Ratio | 2.59 |
| P/TBV Ratio | 2.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -29.47 |
| EV / Sales | 249.49 |
| EV / EBITDA | 16.67 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.37 |
| Quick Ratio | 0.15 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -8.50% and return on invested capital (ROIC) is -8.50%.
| Return on Equity (ROE) | -8.50% |
| Return on Assets (ROA) | -3.48% |
| Return on Invested Capital (ROIC) | -8.50% |
| Return on Capital Employed (ROCE) | -6.22% |
| Weighted Average Cost of Capital (WACC) | 6.13% |
| Revenue Per Employee | 65,178 |
| Profits Per Employee | -551,709 |
| Employee Count | 1 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.03 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +128.24% in the last 52 weeks. The beta is 0.35, so Stem Cells Spin's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +128.24% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.40 |
| Relative Strength Index (RSI) | 47.11 |
| Average Volume (20 Days) | 11,525 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Stem Cells Spin had revenue of PLN 65,178 and -551,709 in losses. Loss per share was -0.01.
| Revenue | 65,178 |
| Gross Profit | 47,847 |
| Operating Income | -551,147 |
| Pretax Income | -551,709 |
| Net Income | -551,709 |
| EBITDA | 975,693 |
| EBIT | -551,147 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 22,101 in cash and 162,083 in debt, with a net cash position of -139,982 or -0.00 per share.
| Cash & Cash Equivalents | 22,101 |
| Total Debt | 162,083 |
| Net Cash | -139,982 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 6.21M |
| Book Value Per Share | 0.15 |
| Working Capital | 394,886 |
Cash Flow
| Operating Cash Flow | -106,795 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.53M |
| Net Borrowing | 128,400 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 73.41% |
| Operating Margin | -845.60% |
| Pretax Margin | -846.47% |
| Profit Margin | n/a |
| EBITDA Margin | 1,496.97% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Stem Cells Spin does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.42% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Stem Cells Spin has an Altman Z-Score of 2.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.59 |
| Piotroski F-Score | 2 |